AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 129 filers reported holding AMNEAL PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $3,734 | +20.6% | 588 | +15.1% | 0.00% | – |
Q1 2024 | $3,097 | +1.6% | 511 | +1.8% | 0.00% | – |
Q4 2023 | $3,047 | +43.9% | 502 | 0.0% | 0.00% | – |
Q3 2023 | $2,118 | +36.1% | 502 | 0.0% | 0.00% | – |
Q2 2023 | $1,556 | +903.9% | 502 | +543.6% | 0.00% | – |
Q4 2022 | $155 | – | 78 | -29.7% | 0.00% | – |
Q3 2022 | $0 | -100.0% | 111 | -84.2% | 0.00% | – |
Q2 2022 | $2,000 | +100.0% | 703 | +328.7% | 0.00% | – |
Q1 2022 | $1,000 | 0.0% | 164 | 0.0% | 0.00% | – |
Q4 2021 | $1,000 | -50.0% | 164 | -61.5% | 0.00% | -100.0% |
Q3 2021 | $2,000 | 0.0% | 426 | 0.0% | 0.00% | – |
Q2 2021 | $2,000 | -33.3% | 426 | 0.0% | 0.00% | -100.0% |
Q1 2021 | $3,000 | +50.0% | 426 | 0.0% | 0.00% | – |
Q4 2020 | $2,000 | 0.0% | 426 | 0.0% | 0.00% | -100.0% |
Q3 2020 | $2,000 | 0.0% | 426 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $2,000 | +100.0% | 426 | 0.0% | 0.00% | – |
Q1 2020 | $1,000 | 0.0% | 426 | +159.8% | 0.00% | – |
Q4 2019 | $1,000 | – | 164 | – | 0.00% | – |
Q4 2018 | $0 | – | 0 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fosun International Ltd | 19,552,001 | $433,859,000 | 20.80% |
BRIDGER MANAGEMENT, LLC | 2,642,621 | $58,640,000 | 3.39% |
TPG Group Holdings (SBS) Advisors, Inc. | 3,884,600 | $86,199,000 | 1.10% |
HUSSMAN STRATEGIC ADVISORS, INC. | 125,000 | $2,774,000 | 0.80% |
HealthCor Management, L.P. | 1,036,110 | $22,991,000 | 0.76% |
GW&K Investment Management, LLC | 2,049,765 | $45,484,000 | 0.73% |
Bridge City Capital, LLC | 50,434 | $1,119,000 | 0.70% |
TCW GROUP INC | 2,521,064 | $55,942,000 | 0.46% |
FRONTIER CAPITAL MANAGEMENT CO LLC | 2,876,367 | $63,827,000 | 0.41% |
Quadrant Capital Management, LLC | 25,002 | $555,000 | 0.35% |